Latest news
UK: Silence Therapeutics announces proposed public offering of US$150m of ADS - Investors in HealthcareInvestors in Healthcare · Tue, 11 Aug 2026 07:56:01 GMTHPE Shares Climb Following Morgan Stanley Upgrade, With $71 Price Target Indicating 30% Upside - TechStock²TechStock² · Mon, 10 Aug 2026 20:44:58 GMTSilence Therapeutics Jumps Over 25% After Divesiran Phase 2 Trial Supports 12-Week Dosing - TechStock²TechStock² · Mon, 10 Aug 2026 20:28:54 GMTSandisk Stock Rebounds as Analysts Reframe the Earnings Selloff - TechStock²TechStock² · Mon, 10 Aug 2026 20:11:59 GMTSilence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares - marketscreener.commarketscreener.com · Mon, 10 Aug 2026 20:02:04 GMTThree Monday Movers Had One Thing In Common: Big News - FinimizeFinimize · Mon, 10 Aug 2026 18:32:33 GMTEuropean ADRs Start The Week Slightly Higher In US Trading - FinimizeFinimize · Mon, 10 Aug 2026 15:26:35 GMTSilence Therapeutics SLN Stock Heats Up Ahead Phase 2 Data - StocksToTradeStocksToTrade · Mon, 10 Aug 2026 13:18:00 GMT